Vreni Schneider

1.2k total citations
13 papers, 952 citations indexed

About

Vreni Schneider is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Vreni Schneider has authored 13 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Vreni Schneider's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Alcohol Consumption and Health Effects (3 papers). Vreni Schneider is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Alcohol Consumption and Health Effects (3 papers). Vreni Schneider collaborates with scholars based in Switzerland, Germany and United States. Vreni Schneider's co-authors include M Ledermann, Markus Neef, Sabina Liechti‐Gallati, Eleonora Patsenker, Felix Stickel, Juerg Reichen, Hans Sägesser, Stephan M. Tanner, Richard Kraemer and Claus Hellerbrand and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Vreni Schneider

13 papers receiving 940 citations

Peers

Countries citing papers authored by Vreni Schneider

Since Specialization

Citations

This map shows the geographic impact of Vreni Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vreni Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vreni Schneider more than expected).

Fields of papers citing papers by Vreni Schneider

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vreni Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vreni Schneider. The network helps show where Vreni Schneider may publish in the future.

Co-authorship network of co-authors of Vreni Schneider

This figure shows the co-authorship network connecting the top 25 collaborators of Vreni Schneider. A scholar is included among the top collaborators of Vreni Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vreni Schneider. Vreni Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Elevated Levels of Endocannabinoids in Chronic Hepatitis C May Modulate Cellular Immune Response and Hepatic Stellate Cell Activation 2015 ·International Journal of Molecular Sciences ·Eleonora Patsenker, (unknown), Andrea Chicca, M. Salomé Gachet, Vreni Schneider, Johan Mattsson, Christian Lanz, Mathias Worni, Andrea De Gottardi, Mariam Semmo, Jochen Hampe, Clemens Schafmayer, Rudolf Brenneisen, Jürg Gertsch, Felix Stickel, Nasser Semmo	34
2	Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis 2011 ·Molecular Medicine ·Eleonora Patsenker, Matthias Stoll, Gunda Millonig, Abbas Agaimy, (unknown), Vreni Schneider, Sebastian Mueller, Rudolf Brenneisen, Helmut K. Seitz, Matthias Ocker, Felix Stickel	61
3	Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis 2010 ·Journal of Hepatology ·Eleonora Patsenker, Vreni Schneider, M Ledermann, (unknown), Christoph Dorn, Claus Hellerbrand, Felix Stickel	105
4	Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis # 2009 ·Hepatology ·Eleonora Patsenker, Yury Popov, Felix Stickel, Vreni Schneider, M Ledermann, Hans Sägesser, Gerald Niedobitek, Simon L. Goodman, Detlef Schuppan	131
5	No Role of Matrixmetalloproteinase‐3 Genetic Promoter Polymorphism 1171 as a Risk Factor for Cirrhosis in Alcoholic Liver Disease 2008 ·Alcoholism Clinical and Experimental Research ·Felix Stickel, Christoph H. Österreicher, Juliane Halangk, Thomas Berg, Nils Homann, Claus Hellerbrand, Eleonora Patsenker, Vreni Schneider, Armin Kolb, Helmut Frieß, Detlef Schuppan, Gero Puhl, Helmut K. Seitz, (unknown), Christopher P. Day	9
6	Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis 2006 ·Journal of Hepatology ·Markus Neef, M Ledermann, (unknown), Vreni Schneider, Juerg Reichen	117
7	Long-Term Treatment of Bile Duct-Ligated Rats with Rapamycin (Sirolimus) Significantly Attenuates Liver Fibrosis: Analysis of the Underlying Mechanisms 2005 ·Journal of Pharmacology and Experimental Therapeutics ·Erwin Biecker, Andrea De Gottardi, Markus Neef, (unknown), Vreni Schneider, M Ledermann, Hans Sägesser, Sidney Shaw, Jürg Reichen	69
8	Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term 2005 ·Journal of Hepatology ·Markus Neef, M Ledermann, (unknown), Vreni Schneider, Nicolas Widmer, Laurent A. Décosterd, Bertrand Rochat, Juerg Reichen	73
9	Photonic Crystal Micro-Cavity Based Radiation Filter 2005 ·Journal of Electromagnetic Waves and Applications ·Haroldo T. Hattori, Andrzej Kaźmierczak, Vreni Schneider, C. L. Barbosa	3
10	Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy 2001 ·Molecular and Biochemical Parasitology ·Enock Matovu, (unknown), Vreni Schneider, Pascal Mäser, John Enyaru, Ronald Kaminsky, Sabina Gallati, Thomas Seebeck	78
11	MTM1 mutations in X-linked myotubular myopathy 2000 ·Human Mutation ·Jocelyn Laporte, (unknown), Stephan M. Tanner, Wolfram Kreß, Vreni Schneider, Carina Wallgren‐Pettersson, (unknown), Anna Buj‐Bello, (unknown), Sabina Liechti‐Gallati, Jean‐Louis Mandel	164
12	Two buffer PAGE system-based SSCP/HD analysis: a general protocol for rapid and sensitive mutation screening in cystic fibrosis and any other human genetic disease 1999 ·European Journal of Human Genetics ·Sabina Liechti‐Gallati, Vreni Schneider, (unknown), Richard Kraemer	74
13	Characterization of 34 novel and six known MTM1 gene mutations in 47 unrelated X-linked myotubular myopathy patients 1999 ·Neuromuscular Disorders ·Stephan M. Tanner, Vreni Schneider, Nick Thomas, Angus Clarke, L. Lazarou, Sabina Liechti‐Gallati	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact